greeksoup/ stock research
Stock research / United States / LGND / Filings

Ligand Pharmaceuticals Inc. SEC filings

Ligand Pharmaceuticals (LGND) filed its 10-Q for the quarter ended 30 June 2026 on 7 August 2026. Its latest SEC filing, on 24 September 2026, was an 8-K: regulation FD disclosure, other events. 27 filings in the last twelve months, each 8-K by what it was about; the 10-K and proxy statement are on the documents page.

In the twelve months since 11 October 2025 Ligand Pharmaceuticals Inc. filed 27 documents with the SEC of the kinds listed here: 15 current reports (8-K), about 5 material agreement; 4 regulation FD disclosure; 4 other events; 4 results of operations; 2 new financial obligation; 4 additional proxy materials (DEFA14A), 3 quarterly reports (10-Q), 1 employee share plan registration (S-8), 1 annual report to shareholders (ARS), 1 proxy statement (DEF 14A), 1 shelf registration (S-3ASR). The latest, filed 24 September 2026: 8-K, regulation FD disclosure, other events. The 10-K, the 10-Qs and the proxy statement themselves, each with a link to open it, are on the documents page.

FiledFormWhat it was aboutPeriod or event dateFiling
24 September 20268-KRegulation FD disclosure, Other events24 September 2026EDGAR
22 September 20268-KRegulation FD disclosure22 September 2026EDGAR
2 September 20268-K/Aamended current report14 July 2026EDGAR
7 August 202610-Qquarterly report30 June 2026EDGAR
6 August 20268-KResults of operations6 August 2026EDGAR
22 July 2026S-8employee share plan registrationEDGAR
14 July 20268-KMaterial agreement, Acquisition or disposition completed, New financial obligation, Regulation FD disclosure14 July 2026EDGAR
25 June 20268-KMaterial agreement, New financial obligation, Unregistered sale of equity, Other events25 June 2026EDGAR
22 June 20268-KMaterial agreement, Other events22 June 2026EDGAR
9 June 20268-KOfficer or director change, Shareholder vote5 June 2026EDGAR
18 May 2026DEFA14Aadditional proxy materialEDGAR
18 May 20268-KMaterial agreement16 May 2026EDGAR
8 May 202610-Qquarterly report31 March 2026EDGAR
7 May 20268-KResults of operations7 May 2026EDGAR
30 April 20268-KTermination of a material agreement24 April 2026EDGAR
28 April 2026DEFA14Aadditional proxy materialEDGAR
27 April 2026DEFA14Aadditional proxy materialEDGAR
27 April 20268-KMaterial agreement, Other events27 April 2026EDGAR
21 April 2026ARSannual report to shareholders31 December 2025EDGAR
21 April 2026DEFA14Aadditional proxy materialEDGAR
21 April 2026DEF 14Aproxy statement31 December 2025EDGAR
27 February 2026S-3ASRshelf registrationEDGAR
27 February 202610-Kannual report31 December 2025EDGAR
26 February 20268-KResults of operations26 February 2026EDGAR
18 December 20258-KRegulation FD disclosure18 December 2025EDGAR
7 November 202510-Qquarterly report30 September 2025EDGAR
6 November 20258-KResults of operations6 November 2025EDGAR
An 8-K is what a company files within four business days of a material event; the SEC numbers the events, and the words here are the SEC's own headings, shortened.
Read moreForm 4, Form 144, 13F and Schedule 13D and 13G have their own pages. Prospectus supplements and correspondence are not listed.

Source

The company's filing index on EDGAR, read from the SEC's submissions feed.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install